Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6988 results

Sort By:

The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.

Study ID: NCT06536517
Start Date: 2025-03-07
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Methadone

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Study ID: NCT06856226
Start Date: 2025-12-16
End Date: 2028-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

88

Intervention / Treatment

Arm 1

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

Study ID: NCT05789589
Start Date: 2023-11-17
End Date: 2027-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

46

Intervention / Treatment

Azeliragon

Stereotactic radiosurgery

Corticosteroid

Sponsor

Baptist Health South Florida

Source: clinicaltrials.gov

Share:
Add to list

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

Study ID: NCT04278118
Start Date: 2020-02-18
End Date: 2031-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Hypofractionated Radiation Therapy

Photon Beam Radiation Therapy

Proton Beam Radiation Therapy

Quality-of-Life Assessment

Administration Questionnaire

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

Study ID: NCT05194397
Start Date: 2023-02-23
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Nicotinamide Riboside

Placebo

Exercise Intervention

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

Study ID: NCT03010150
Start Date: 2016-12-29
End Date: 2028-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

471

Intervention / Treatment

Biospecimen Collection

Administration Questionnaire

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

Study ID: NCT06028074
Start Date: 2023-12-12
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

111

Intervention / Treatment

GIM122

Sponsor

Georgiamune Inc

Source: clinicaltrials.gov

Share:
Add to list

Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx

Study ID: NCT04667585
Start Date: 2021-04-12
End Date: 2028-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

De-escalated radiation dose

Standard radiation dose

18 fluorodeoxyglucose (FDG)-positron emission tomography (PET)-Computed Tomography (CT)

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

Study ID: NCT06156410
Start Date: 2023-10-24
End Date: 2028-11
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Cabozantinib

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

Study ID: NCT06880991
Start Date: 2025-04-29
End Date: 2027-03-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

110

Intervention / Treatment

Arm 1

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list